122 related articles for article (PubMed ID: 38551915)
1. The Utility of Serum Alpha-fetoprotein for Monitoring for Relapse of Alpha-fetoprotein-Positive Hepatoblastoma.
Davini M; Hastings C; Feusner J
J Pediatr Hematol Oncol; 2024 May; 46(4):206-210. PubMed ID: 38551915
[TBL] [Abstract][Full Text] [Related]
2. Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging.
Rojas Y; Guillerman RP; Zhang W; Vasudevan SA; Nuchtern JG; Thompson PA
Pediatr Radiol; 2014 Oct; 44(10):1275-80. PubMed ID: 24839140
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant trends in α-fetoprotein levels as a predictor of recurrence after living donor liver transplantation for unresectable hepatoblastoma: A single-institution experience.
Isono K; Ohya Y; Lee KJ; Hashimoto S; Kadohisa M; Sakisaka M; Uto K; Hayashida S; Yamamoto H; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2018 Aug; 22(5):e13221. PubMed ID: 29761829
[TBL] [Abstract][Full Text] [Related]
4. Serum α-fetoprotein concentration in extremely low-birthweight infants.
Maruyama K
Pediatr Int; 2017 Feb; 59(2):159-162. PubMed ID: 27400853
[TBL] [Abstract][Full Text] [Related]
5. Glypican 3 as a Serum Marker for Hepatoblastoma.
Zhou S; O'Gorman MR; Yang F; Andresen K; Wang L
Sci Rep; 2017 Apr; 7():45932. PubMed ID: 28378832
[TBL] [Abstract][Full Text] [Related]
6. [Successful treatment of second hepatoblastoma relapse--case report].
Krstovski N; Radlović N; Janić D; Dokmanović L; Smoljanić Z; Sretenović A
Acta Chir Iugosl; 2009; 56(2):105-8. PubMed ID: 19780340
[TBL] [Abstract][Full Text] [Related]
7. The role of subfractionation of alpha-fetoprotein in the treatment of pediatric surgical patients.
Tsuchida Y; Terada M; Honna T; Kitano Y; Obana K; Leibundgut K; Ishiguro T
J Pediatr Surg; 1997 Mar; 32(3):514-7. PubMed ID: 9094031
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
[TBL] [Abstract][Full Text] [Related]
9. Can we predict the prognosis of resectable hepatoblastoma from serum alpha-fetoprotein response during preoperative chemotherapy?
Fukuzawa H; Urushihara N; Fukumoto K; Mitsunaga M; Watanabe K; Aoba T; Yamoto S; Miyake H; Hasegawa S
Pediatr Surg Int; 2012 Sep; 28(9):887-91. PubMed ID: 22948667
[TBL] [Abstract][Full Text] [Related]
10. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
[TBL] [Abstract][Full Text] [Related]
11. Effect of postoperative chemotherapy on the serum alpha-fetoprotein level in hepatoblastoma.
Kubota M; Yagi M; Kanada S; Yamazaki S; Tanaka S; Asami K; Ogawa A; Watanabe A; Iwabuchi H; Kaneko M; Saida Y
J Pediatr Surg; 2004 Dec; 39(12):1775-8. PubMed ID: 15616926
[TBL] [Abstract][Full Text] [Related]
12. A case of well-differentiated, fetal-type hepatoblastoma with very low serum alpha-fetoprotein.
Tsuchida Y; Ikeda H; Suzuki N; Takahashi A; Kuroiwa M; Sakai M; Shimizu H; Shitara T; Yamanouchi H; Hirato J
J Pediatr Surg; 1999 Dec; 34(12):1762-4. PubMed ID: 10626849
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors: preliminary study.
Kinoshita Y; Tajiri T; Souzaki R; Tatsuta K; Higashi M; Izaki T; Takahashi Y; Taguchi T
J Pediatr Hematol Oncol; 2008 Jun; 30(6):447-50. PubMed ID: 18525461
[TBL] [Abstract][Full Text] [Related]
14. Treatment of alpha-fetoprotein secreting hepatoblastoma by response of serum alpha-fetoprotein levels: a new concept.
Sayar D; Yaniv I; Goshen Y; Cohen IJ
Pediatr Hematol Oncol; 2001 Dec; 18(8):509-18. PubMed ID: 11764100
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and prognosis factors for advanced hepatoblastoma in children: a 6-year retrospective study.
Zhang Y; Zhang WL; Huang DS; Hong L; Wang YZ; Zhu X; Hu HM; Zhang PW; Yi Y; Han T
Asian Pac J Cancer Prev; 2013; 14(8):4583-9. PubMed ID: 24083706
[TBL] [Abstract][Full Text] [Related]
16. Circulating D-dimer level correlates with disease characteristics in hepatoblastoma patients.
Zhang B; Liu G; Liu X; Zheng S; Dong K; Dong R
Medicine (Baltimore); 2017 Nov; 96(47):e8798. PubMed ID: 29381980
[TBL] [Abstract][Full Text] [Related]
17. DLK1, a serum marker for hepatoblastoma in young infants.
Falix FA; Aronson DC; Lamers WH; Hiralall JK; Seppen J
Pediatr Blood Cancer; 2012 Oct; 59(4):743-5. PubMed ID: 22180200
[TBL] [Abstract][Full Text] [Related]
18. Hepatoblastoma in Explanted Livers of Patients With Biliary Atresia.
Amir AZ; Sharma A; Cutz E; Avitzur Y; Shaikh F; Kamath BM; Ling SC; Ghanekar A; Ng VL
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):188-94. PubMed ID: 27457778
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.
MacDonell-Yilmaz R; Anderson K; DeNardo B; Sprinz P; Padula WV
J Pediatr; 2020 Oct; 225():80-89.e4. PubMed ID: 32470475
[TBL] [Abstract][Full Text] [Related]
20. α-Fetoprotein assay on dried blood spot for hepatoblastoma screening in children with overgrowth-cancer predisposition syndromes.
Mussa A; Pagliardini S; Pagliardini V; Molinatto C; Baldassarre G; Corrias A; Silengo MC; Ferrero GB
Pediatr Res; 2014 Dec; 76(6):544-8. PubMed ID: 25167201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
